Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion

BACKGROUND: Multiple myeloma (MM) is the second most common hematological malignancy that still lacks effective clinical treatments. In particular, MM with central nervous system (CNS) invasion occurs rarely. Although B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor-T (CAR-T) cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, He, Ting, Ma, Lie, Yang, Yazi, Feng, Ru, Ding, Yanping, Shan, Yueming, Bu, Bing, Qi, Feifei, Wu, Fei, Lu, Xin-an, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150173/
https://www.ncbi.nlm.nih.gov/pubmed/35651792
http://dx.doi.org/10.3389/fonc.2022.854448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150173/
https://www.ncbi.nlm.nih.gov/pubmed/35651792
http://dx.doi.org/10.3389/fonc.2022.854448

Ejemplares similares